The Medicines and Healthcare products Regulatory Agency approves the use of Pfizer's anti-viral oral drug Paxlovid for high-risk patients. (The Independent) COVID-19 pandemic in the United Kingdom, COVID-19 drug developmentCOVID-19 pandemic in EuropeCOVID-19 pandemic link embed save